PCRX Operating Cash Flow (Statement)
Pacira Biosciences Inc · Operating Cash Flow (Statement)
PCRX Operating Cash Flow (Statement)
Latest reported$187.66Mperiod ending
PCRX Cash from Operations (-$29.19M → $187.66M)
Annual operating cash flow (statement)
High-resolution chart · PNG
PCRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 151,994,000 | |
| 189,389,000 | |
| 154,649,000 | |
| 145,274,000 | |
| 125,717,000 | |
| 77,032,000 | |
| 70,520,000 | |
| 48,870,000 | |
| 17,785,000 | |
| 33,453,000 | |
| 28,996,000 | |
| 25,469,000 | |
| -43,216,000 | |
| -70,130,000 | |
| -31,000,000 | |
| -24,880,000 | |
| -20,838,000 | |
| -29,189,000 |